M-Health: Efficacy and Cost-effectiveness of a smartphone App to reduce unmet needs and distress in people with cancer (ACE): a randomized controlled trial
M-Health:智能手机应用程序减少癌症患者未满足的需求和痛苦的功效和成本效益 (ACE):一项随机对照试验
基本信息
- 批准号:nhmrc : 1094831
- 负责人:
- 金额:$ 26.29万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:Partnerships
- 财政年份:2015
- 资助国家:澳大利亚
- 起止时间:2015-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Patients experience significant levels of both psychological distress and unmet needs during cancer treatment. This study will trial an innovative approach to streamlining best practice in cancer management through the use of Smartphone technology. Given the reach of Smartphones, should this trial prove successful, it will provide the basis for additional modules supporting specific areas of care such as management of chemotherapy side effects and treatment compliance.
在癌症治疗期间,患者经历了显著的心理困扰和未满足的需求。这项研究将尝试一种创新的方法,通过使用智能手机技术来简化癌症管理的最佳实践。鉴于智能手机的普及,如果这项试验证明是成功的,它将为支持特定护理领域(如化疗副作用管理和治疗依从性)的其他模块提供基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A/Pr Cathrine Mihalopoulos其他文献
A/Pr Cathrine Mihalopoulos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A/Pr Cathrine Mihalopoulos', 18)}}的其他基金
PRevention & Early intervention in Mental Illness and Substance usE (PREMISE CRE)
预防
- 批准号:
nhmrc : 1134909 - 财政年份:2018
- 资助金额:
$ 26.29万 - 项目类别:
Centres of Research Excellence
Individualised vocational support for youth with borderline personality disorder: A randomised controlled trial
为患有边缘性人格障碍的青少年提供个性化职业支持:一项随机对照试验
- 批准号:
nhmrc : 1144022 - 财政年份:2018
- 资助金额:
$ 26.29万 - 项目类别:
Project Grants
Building the Evidence Base for Prevention and Recovery Care Services
建立预防和康复护理服务的证据基础
- 批准号:
nhmrc : 1115907 - 财政年份:2016
- 资助金额:
$ 26.29万 - 项目类别:
Partnerships
Determining the Best Outcome Measures for Assessing Cost-Effectiveness of Interventions for Childhood Mental Disorders
确定评估儿童精神障碍干预措施成本效益的最佳结果指标
- 批准号:
nhmrc : 1105187 - 财政年份:2016
- 资助金额:
$ 26.29万 - 项目类别:
Project Grants
EMPOWER: Early Signs Monitoring to Prevent Relapse and PrOmote Wellbeing, Engagement and Recovery.
EMPOWER:早期体征监测以防止复发并促进健康、参与和康复。
- 批准号:
nhmrc : 1095879 - 财政年份:2015
- 资助金额:
$ 26.29万 - 项目类别:
Targeted Calls
Preventing Child Internalising Problems: Follow up of a population-based randomised trial through middle childhood.
预防儿童内化问题:对童年中期的一项基于人群的随机试验进行跟踪。
- 批准号:
nhmrc : 1079956 - 财政年份:2015
- 资助金额:
$ 26.29万 - 项目类别:
Project Grants
A randomised trial of a clinical prediction tool for targeting depression care (Target-D)
针对抑郁症护理的临床预测工具的随机试验 (Target-D)
- 批准号:
nhmrc : 1059863 - 财政年份:2014
- 资助金额:
$ 26.29万 - 项目类别:
Project Grants
Reducing peer victimisation in Australian schools through targeted and universal approaches
通过有针对性和普遍的方法减少澳大利亚学校的同伴受害
- 批准号:
nhmrc : 1047185 - 财政年份:2013
- 资助金额:
$ 26.29万 - 项目类别:
Targeted Calls
The Australian perinatal mental health reforms: using population data to evaluate their impact on service utilisation and related cost-effectiveness
澳大利亚围产期心理健康改革:利用人口数据评估其对服务利用和相关成本效益的影响
- 批准号:
nhmrc : 1028554 - 财政年份:2012
- 资助金额:
$ 26.29万 - 项目类别:
Partnerships
Evidence-based Mental Health Planning: Translating Evidence into Policy and Services
循证心理健康规划:将证据转化为政策和服务
- 批准号:
nhmrc : 1041131 - 财政年份:2012
- 资助金额:
$ 26.29万 - 项目类别:
Centres of Research Excellence
相似海外基金
Efficacy and cost-effectiveness of Internet cognitive behavioral therapy for irritable bowel syndrome
互联网认知行为疗法治疗肠易激综合征的疗效和成本效益
- 批准号:
23K12915 - 财政年份:2023
- 资助金额:
$ 26.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Randomized Controlled Trial of Dyadic Financial Incentive Treatment for Dual Smoker Couples: Evaluation of Efficacy, Mechanisms, and Cost Effectiveness
双烟夫妇二元经济激励治疗的随机对照试验:疗效、机制和成本效益评估
- 批准号:
10734422 - 财政年份:2023
- 资助金额:
$ 26.29万 - 项目类别:
Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE)
ScreenFire(一种低成本 HPV 检测)的单次临床验证:功效和成本效益 (SCALE)
- 批准号:
10595668 - 财政年份:2022
- 资助金额:
$ 26.29万 - 项目类别:
Rapid high throughput cost effective evaluation of viral vector efficacy Rapid image pattern analysis microfluidic cell cultures using AI algorithms
快速高通量、经济有效地评估病毒载体功效 使用 AI 算法快速图像模式分析微流体细胞培养物
- 批准号:
BB/X511250/1 - 财政年份:2022
- 资助金额:
$ 26.29万 - 项目类别:
Training Grant
Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE)
ScreenFire(一种低成本 HPV 检测)的单次临床验证:功效和成本效益 (SCALE)
- 批准号:
10340927 - 财政年份:2022
- 资助金额:
$ 26.29万 - 项目类别:
Towards rapid, high-throughput and cost-effective evaluation of viral vector efficacy: Rapid image pattern analysis from microfluidic cell cultures us
对病毒载体功效进行快速、高通量和具有成本效益的评估:使用微流体细胞培养物进行快速图像模式分析
- 批准号:
2747236 - 财政年份:2022
- 资助金额:
$ 26.29万 - 项目类别:
Studentship
A practice change for patients with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled intervention to assess efficacy and cost-effectiveness
针对患有严重慢性、临床无法解释的胃肠道症状的患者的做法改变:评估疗效和成本效益的随机、对照干预措施
- 批准号:
nhmrc : 2004495 - 财政年份:2021
- 资助金额:
$ 26.29万 - 项目类别:
Ideas Grants
Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.
评估南非艾滋病毒感染者戒烟干预措施:功效、实施和成本效益。
- 批准号:
10269650 - 财政年份:2021
- 资助金额:
$ 26.29万 - 项目类别:
Safety, efficacy, and cost-effectiveness of rituximab for multicentric Castleman disease in Malawi
利妥昔单抗治疗马拉维多中心 Castleman 病的安全性、有效性和成本效益
- 批准号:
10018127 - 财政年份:2019
- 资助金额:
$ 26.29万 - 项目类别:
Real-World Evaluation of the Efficacy, Safety and Cost-Effectiveness of Statins for Primary Prevention of Cardiovascular Disease Among the Elderly - A Causal Perspective to Treatment Trajectory Analysis
他汀类药物用于老年人心血管疾病一级预防的有效性、安全性和成本效益的真实世界评价——治疗轨迹分析的因果视角
- 批准号:
402053 - 财政年份:2019
- 资助金额:
$ 26.29万 - 项目类别:
Operating Grants